REQUEST A DEMO
Total
USD $0.00
Search more companies

Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd. Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd. is a listed company on the Growth Enterprise Market, controlled by Gansu Pharmaceutical Investment Group Co., Ltd. The company is located at No. 138 Jinkelou Road, Dingyuan Town, Dingliang Garden District, Lanzhou City, Gansu Province. It has a registered capital of 303.345 million yuan and employs over 600 people. The company is primarily engaged in the research, development, production, and sales of traditional Chinese medicine and health food. It is also involved in the cultivation, acquisition, processing, sales, and distribution of Chinese medicinal materials. The company has two wholly-owned subsidiaries and two holding companies. It has been recognized as a national high-tech enterprise and a strategic emerging industry backbone enterprise in Gansu Province. The company has received numerous honors and titles, including the AA-level enterprise quality credit rating in Gansu Province and the Gansu Province Science and Technology Progress Second Prize. Its main products include Yuanhu Zhitong Pills, Xuanfei Zhisou Mixture, Qiwu Wenyang Capsules, Mazaozhike Capsules, and Suanniren Oil Pills. The company aims to become a leading enterprise in the Gansu pharmaceutical industry, with a complete industrial chain integrating standardized Chinese medicine planting, deep processing of Chinese medicinal materials, new drug research and development, modern Chinese medicine production, and pharmaceutical trade logistics.

Headquarters
No. 10, National Defense Road, Dingyuan Town, Yuzhong County, Lanzhou City, Gansu Province
Lanzhou; Gansu; Postal Code: 730102

Contact Details: Purchase the Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd. report to view the information.

Website: http://www.lsrfzy.com

Basic Information
Total Employees:
Purchase the Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd. report to view the information.
Incorporation Date:
June 03, 2002
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
29.93%
Purchase this report to view the information.
7.11%
Purchase this report to view the information.
0.62%
Purchase this report to view the information.
0.55%
Purchase this report to view the information.
0.48%
Subsidiaries
Gansu New Silk Road Industry Investment Co., Ltd.
Gansu Pharmaceutical Group Operation Co., Ltd
Gansu Pharmaceutical Group Sanyuan Pharmaceutical Co., Ltd.
Company Performance
Financial values in the chart are available after Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-0.75%
Total operating revenue
-0.68%
Operating profit (EBIT)
-2.17%
Net Profit (Loss) for the Period
-24.45%
Total assets
3.75%
Total equity
4.74%
Operating Profit Margin (ROS)
-0.13%
Net Profit Margin
-1.85%
Return on Equity (ROE)
-2.55%
Debt to Equity Ratio
-6.07%
Quick Ratio
-0.01%
Cash Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?